Results 221 to 230 of about 4,465,471 (397)
Human research ethics committees: Beyond critique to participation
, 2014 Simon Batterbury
openalex +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
Ethical issues and the role of the ethics committees during COVID-19 research in pandemic era: a focus on an Italian ethics committee. [PDF]
Front Public HealthTattoli L +4 more
europepmc +1 more source
A Call for Better, Not Faster, Research Ethics Committee Reviews in the Covid-19 Era. [PDF]
Ethics Hum Res, 2021 Tamariz L +4 more
europepmc +1 more source
Independent Ethics Committee Applicant [PDF]
, 2020 National Cancer Institute
openalex +1 more source
SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas +18 more
wiley +1 more source
Committee on Publication Ethics (COPE): Guidelines on Good Publication Practice
, 2000 openalex +1 more source